Artificial Intelligence Application in Cornea and External Diseases
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Machine Learning and Artificial Intelligence in Diagnostics".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 221
Special Issue Editors
Interests: bioengineering; ocular surface; stem cells
Special Issue Information
Dear Colleagues,
AI has attracted the attention of diverse medical disciplines. It has exhibited promise in enhancing the efficiency of healthcare via supporting automated clinical diagnoses through complex analyses across numerous dimensions. Moreover, it has the potential to decrease the reliance on expensive diagnostic tools and personnel, facilitating improved healthcare delivery. Furthermore, the recent global health crisis caused by the COVID-19 pandemic has significantly affected patients and services in the field of ophthalmology, underscoring the significance of digital healthcare. Within the realm of ophthalmology, AI has proven to possess diagnostic precision akin to that of medical professionals in identifying conditions such as macular degeneration, glaucoma, and diabetic retinopathy. However, there is still a need for expanded research and development in the areas of the cornea and anterior segment. Scientific teams worldwide have evaluated the effectiveness of AI algorithms in diagnosing various diseases of the anterior segment of the eye. In this Special Issue, we aim to cover the latest innovations and advancements in the application of AI in the diagnosis, monitoring, and management of cornea and ocular surface conditions.
Dr. Ali R. Djalilian
Dr. Mohammad Soleimani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- artificial intelligence
- machine learning
- cornea
- ocular surface
- ophthalmology
- external eye diseases
- mobile health
- telemedicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
